Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease, Novo Nordisk said.

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.

Spread This NewsCity Press Globally, people wanting to lose weight are turning to Ozempic, the so-called miracle drug ...

Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Novo, which competes with U.S. drugmaker Eli Lilly, makes the main active ingredient in its popular obesity and diabetes ...

Brandee McKoon tried the traditional diets to lose weight but didn’t have much luck. The Kokomo woman was prediabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually ...

COPENHAGEN - The CEO of obesity drugmaker Novo Nordisk and heads of other Danish companies met on Thursday with Denmark's ...

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey. Maryland’s federal workers ‘living life of uncertainty’ after Trump ...

Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...

Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has US headquarters Plainsboro, New Jersey.